Directory
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Degree: PhD

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publications

  • Martinez-Garcia, E; Lesur, A; Devis, L; Cabrera, S; Matias-Guiu, X; Hirschfeld, M; Asberger, J; van Oostrum, J; Casares de Cal MLÁ; Gomez-Tato, A; Reventos, J; Domon, B; Colas, E; Gil-Moreno, A

    Targeted Proteomics Identifies Proteomic Signatures in Liquid Biopsies of the Endometrium to Diagnose Endometrial Cancer and Assist in the Prediction of the Optimal Surgical Treatment

    CLINICAL CANCER RESEARCH 23 6458-6467. .

    [doi:10.1158/1078-0432.CCR-17-0474]

  • Garrido, P; Aldaz, A; Calleja, MA; de Alava, E; Lamas, MJ; Martin, M; Matias-Guiu, X; Palacios, J; Vera, R

    Proposal for the Creation of a National Strategy for Precision Medicine in Cancer: a position statement of SEOM, SEAP and SEFH

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 41 688-691. .

    [doi:10.7399/fh.10877]

  • Novell, A; Morales, S; Valls J; Panades, MJ; Salud, A; Iglesias, E; Vilardell, F; Matias-Guiu, X; Llombart-Cussac, A

    Novel biomarkers in primary breast core biopsies to predict poor response to neoadjuvant chemotherapy and appearance of metastases

    HISTOLOGY AND HISTOPATHOLOGY 32 909-915. .

    [doi:10.14670/HH-11-849]

  • Le Gallo, M; Rudd, ML; Urick, ME; Hansen, NF; Zhang, S; NISC Comparative Sequencing Program; Lozy F; Sgroi DC; Vidal Bel A; Matias-Guiu X; Broaddus RR; Lu KH; Levine DA; Mutch DG; Goodfellow PJ; Salvesen HB; Mullikin JC; Bell DW

    Somatic Mutation Profiles of Clear Cell Endometrial Tumors Revealed by Whole Exome and Targeted Gene Sequencing

    CANCER 123 3261-3268. .

    [doi:10.1002/cncr.30745]

  • Altadill, T; Dowdy, TM; Gill, K; Reques, A; Menon, SS; Moiola, CP; Lopez-Gil, C; Coll, E; Matias-Guiu, X; Cabrera, S; Garcia, A; Reventos, J; Byers, SW; Gil-Moreno, A; Cheema, AK; Colas, E

    Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis

    SCIENTIFIC REPORTS 7 8803-8803. .

    [doi:10.1038/s41598-017-09169-2]

  • Eritja, N; Felip, I; Dosil, MA; Vigezzi, L; Mirantes, C; Yeramian, A; Navaridas, R; Santacana, M; Llobet-Navas, D; Yoshimura, A; Nomura, M; Encinas, M; Matias-Guiu, X; Dolcet, X

    A Smad3-PTEN regulatory loop controls proliferation and apoptotic responses to TGF-beta in mouse endometrium

    CELL DEATH AND DIFFERENTIATION 24 1443-1458. .

    [doi:10.1038/cdd.2017.73]

  • Alsina-Sanchis, E; Figueras, A; Lahiguera, A; Gil-Martin, M; Pardo, B; Piulats, JM; Marti, L; Ponce, J; Matias-Guiu, X; Vidal, A; Villanueva, A; Viñals F

    TGF Controls Ovarian Cancer Cell Proliferation

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 18 -. .

    [doi:10.3390/ijms18081658]

  • Alfon, J.; Erazo, T.; Perez-Montoyo, H.; Domenech, C.; Puig, T.; Segura, M. F.; Matias-Guiu, X.; Rodon, J.; Nadal, E.; Oaknin, A.; Gil, M.; Vidal, L.; Gascon, P.; Lizcano, J. M.

    ABTL0812 AN AUTOPHAGY-ANTICANCER DRUG IN PHASE II CLINICAL TRIALS THAT INHIBITS PI3K/AKT/MTOR PATHWAY BY INDUCING TRIB3 EXPRESSION

    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 121 30-30. .

  • Curras-Freixes, M; Piñeiro-Yañez E; Montero-Conde, C; Apellaniz-Ruiz, M; Calsina, B; Mancikova, V; Remacha, L; Richter, S; Ercolino, T; Rogowski-Lehmann, N; Deutschbein, T; Calatayud, M; Guadalix, S; Alvarez-Escola, C; Lamas, C; Aller, J; Sastre-Marcos, J; Lazaro, C; Galofre, JC; Patiño-García A; Meoro-Aviles, A; Balmaña-Gelpi J; De Miguel-Novoa, P; Balbin, M; Matias-Guiu, X; Leton, R; Inglada-Perez, L; Torres-Perez, R; Roldan-Romero, JM; Rodriguez-Antona, C; Fliedner SMJ; Opocher, G; Pacak, K; Korpershoek, E; de Krijger, RR; Vroonen, L; Mannelli, M; Fassnacht, M; Beuschlein, F; Eisenhofer, G; Cascon, A; Al-Shahrour, F; Robledo, M

    A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics

    Journal Of Molecular Diagnostics 19 575-588. .

    [doi:10.1016/j.jmoldx.2017.04.009]

  • Maiques, O; Moreno, S; Romero, M; Santacana, M; Gomez, I; Velasco, A; Macia, A; Barcelo, C; Boix, R; Valls, J; Gatius, S; Canti, C; Matias-Guiu, X; Soria, X; Marti, RM

    Differential immunoexpression of senescence markers, tumor suppressor genes, BRAF-V600E and T-type calcium channels in acquired nevi according to their histopathological and dermoscopic classification

    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 31 65-65. .

  • Dosil, MA; Mirantes, C; Eritja, N; Felip, I; Navaridas, R; Gatius, S; Santacana, M; Colàs E; Moiola, C; Schoenenberger, JA; Encinas, M; Gari, E; Matias-Guiu, X; Dolcet, X

    Palbociclib has antitumour effects on Pten-deficient endometrial neoplasias

    JOURNAL OF PATHOLOGY 242 152-164. .

    [doi:10.1002/path.4896]

  • Barcelo, C; Maiques, O; Panosa, A; Pijuan, J; Orgaz, JL; Vilella, R; Fabra, A; Puig, S; Sanz-Moreno, V; Matias-Guiu, X; Herreros, J; Canti, C; Macia, A; Marti, RM

    T-type calcium channel blockers reduce migration/invasion in BRAFV600E melanoma cells by inhibiting autophagy

    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 31 66-66. .

Projects

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
  • Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment